Overview Financials News + Filings Key Docs Charts Ownership Insiders
|
|
ESCALADE INC (ESCA)
|
Add to portfolio |
|
|
|
| Price: |
$21.09
| | Metrics |
| OS: |
13.7
|
M
| |
|
|
| Market cap: |
$290
|
M
| |
|
|
|
Net debt:
|
$84
|
M
| |
|
|
|
EV:
|
$374
|
M
| | | |
| | | | | |
| TTM Valuation | | | |
|
EBITDA
|
|
| |
|
|
|
EBIT
|
|
| |
|
|
| EPS |
| |
|
|
|
|
| |
|
|
|
Recent News + Filings (All items)
|
Revenue Mix by Segment
|
Financial Summary (All financials)
| In millions, except per share items | Dec-31-22 | Dec-25-21 | Dec-26-20 | Dec-28-19 | Dec-29-18 | Dec-30-17 | Dec-31-16 | Mar-19-16 |
| Revenues | 313.8 | 313.6 | 273.6 | 180.5 | 175.8 | 195.8 | 171.7 | 156.7 |
| Revenue growth | 0.0% | 14.6% | 51.6% | 2.7% | -10.2% | 14.0% | 7.6% | 9.1% |
| Cost of goods sold | 240.1 | 236.5 | 198.8 | 138.2 | 130.8 | 132.6 | 127.4 | 113.0 |
| Gross profit | 73.6 | 77.1 | 74.8 | 42.4 | 45.0 | 63.2 | 44.3 | 43.7 |
| Gross margin | 23.5% | 24.6% | 27.3% | 23.5% | 25.6% | 32.3% | 25.8% | 27.9% |
| Selling, general and administrative | 44.8 | 43.4 | 40.3 | 31.6 | 29.8 | 28.5 | 27.4 | 29.6 |
| EBITA | 28.9 | 33.8 | 34.5 | 10.7 | 15.3 | 17.8 | 18.6 | 16.4 |
| EBITA margin | 9.2% | 10.8% | 12.6% | 6.0% | 8.7% | 9.1% | 10.8% | 10.5% |
| Amortization of intangibles | 2.6 | 1.9 | 1.5 | 1.5 | 1.4 | 1.6 | 2.3 | 3.0 |
| EBIT | 26.3 | 31.9 | 33.0 | 9.3 | 13.9 | 16.2 | 16.3 | 13.4 |
| EBIT margin | 8.4% | 10.2% | 12.1% | 5.1% | 7.9% | 8.3% | 9.5% | 8.5% |
| Pre-tax income | 22.6 | 30.5 | 32.9 | 8.9 | 26.4 | 15.5 | 15.5 | 13.2 |
| Income taxes | 4.6 | 6.1 | 7.0 | 1.7 | 6.0 | 1.5 | 4.0 | 3.4 |
| Tax rate | 20.5% | 20.1% | 21.2% | 18.8% | 22.7% | 9.4% | 26.1% | 25.6% |
| Net income | 18.0 | 24.4 | 25.9 | 7.3 | 20.4 | 14.1 | 11.5 | 9.8 |
| Net margin | 5.7% | 7.8% | 9.5% | 4.0% | 11.6% | 7.2% | 6.7% | 6.3% |
| |
| Diluted EPS | $1.31 | $1.76 | $1.82 | $0.50 | $1.41 | $0.98 | $0.80 | $0.69 |
| Shares outstanding (diluted) | 13.7 | 13.9 | 14.2 | 14.4 | 14.5 | 14.4 | 14.3 | 14.1 |
| |
| EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |
|
|